Advertisement
Letter to the Editor| Volume 153, P5-7, August 2021

Download started.

Ok

Axitinib-related cardiac dysfunction occurring after resumption of treatment

      Camastra et al. [
      • Camastra G.
      • Arcari L.
      • Ciolina F.
      • Danti M.
      • Cacciotti L.
      Cardiac magnetic resonance imaging of transient myocardial dysfunction in a patient treated with checkpoint-targeted immunotherapy.
      ] reported cardiac magnetic resonance imaging (CMR) of takotsubo cardiomyopathy–like myocardial dysfunction associated with checkpoint-targeted immunotherapy and the usefulness of CMR mapping in diagnosis. Non-invasive imaging modalities circumvent the need for patients with cancer to undergo invasive examinations. Accordingly, we used CMR mapping to diagnose an axitinib-related cardiac dysfunction. Axitinib, a tyrosine kinase inhibitor (TKI), is a potent and selective inhibitor of vascular endothelial growth factor receptors. Hypertension is a common cardiovascular complication, although cardiac dysfunction is rare. Therefore, we report a case of cardiac dysfunction that occurred after axitinib resumption despite the patient's history of long-term axitinib treatment without prior adverse effects. In this case, there were no symptoms or elevated myocardial enzymes, and a slight electrocardiogram (ECG) abnormality triggered the diagnosis, which was made based on echocardiography and CMR.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Cancer
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Camastra G.
        • Arcari L.
        • Ciolina F.
        • Danti M.
        • Cacciotti L.
        Cardiac magnetic resonance imaging of transient myocardial dysfunction in a patient treated with checkpoint-targeted immunotherapy.
        Eur J Canc. 2021; 144: 389-391
        • Ferreira V.M.
        • Schulz-Menger J.
        • Holmvang G.
        • Kramer C.M.
        • Carbone I.
        • Sechtem U.
        • et al.
        Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations.
        J Am Coll Cardiol. 2018; 72: 3158-3176
        • Galán-Arriola C.
        • Lobo M.
        • Vílchez-Tschischke J.P.
        • López G.J.
        • de Molina-Iracheta A.
        • Pérez-Martínez C.
        • et al.
        Serial magnetic resonance imaging to identify early stages of anthracycline-induced cardiotoxicity.
        J Am Coll Cardiol. 2019; 73: 779-791
        • Mahrholdt H.
        • Goedecke C.
        • Wagner A.
        • Meinhardt G.
        • Athanasiadis A.
        • Vogelsberg H.
        • et al.
        Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology.
        Circulation. 2004; 109: 1250-1258
        • Ovadia D.
        • Esquenazi Y.
        • Bucay M.
        • Bachier C.R.
        Association between takotsubo cardiomyopathy and axitinib: case report and review of the literature.
        J Clin Oncol. 2015; 33: 1-3
        • Chu T.F.
        • Rupnick M.A.
        • Kerkela R.
        • Dallabrida S.M.
        • Zurakowski D.
        • Nguyen L.
        • et al.
        Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib.
        Lancet. 2007; 370: 2011-2019
        • Guo C.W.
        • Alexander M.
        • Dib Y.
        • Lau P.K.H.
        • Weppler A.M.
        • Au-Yeung G.
        • et al.
        A closer look at immune-mediated myocarditis in the era of combined checkpoint blockade and targeted therapies.
        Eur J Canc. 2020; 124: 15-24
        • Plana J.C.
        • Galderisi M.
        • Barac A.
        • Ewer M.S.
        • Ky B.
        • Scherrer-Crosbie M.
        • et al.
        Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.
        Eur Heart J Cardiovasc Imag. 2014; 15: 1063-1093